$HLXA News
Last published 1y ago
- 1y agoANABDSGNPSTXXERS+1Bright Peak Therapeutics Appoints John Schmid to its Board of DirectorsGlobeNewswireSAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer,
- 5y agoDVCRHLXARRDSBEAMoore Kuehn Encourages SBEA, RRD, HLXA, and DVCR Investors to Contact Law FirmGlobeNewswireNEW YORK, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair t
- 5y agoHLXAMoonLake Immunotherapeutics AG and Helix Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing Tri-specific Nanobody® SonelokimabBusiness Wire- Total proceeds expected to be approximately $230 million, combining funds held in Helix Acquisition Corp's trust account and a private investment in public entity (PIPE) financing - Leading institutional investors commit $115 million through a PI